Oncology Generic Medicines - Additions
Supply of oncology generic medicines to NHS Scotland
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£17,077,727
Published
22 Jun 2021
Closes
13 Apr 2021
Procurement details
Source
Find a Tender
Region
Scotland
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 2 Everolimus Tablets
£1,583,829
Supply of everolimus tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to three (3) Framework Participants.
Delivery: Scotland
Lot 3 Dasatinib Tablets
£5,498,762
Supply of dasatinib tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to two (2) Framework Participants.
Delivery: Scotland
Lot 4 Cabazitaxel, Fulvestrant and Vinorelbine
£6,875,366
Supply of cabazitaxel, fulvestrant and vinorelbine to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.
Delivery: Scotland
Lot 6 Pemetrexed Solution for Infusion
£2,531,443
Supply of pemetrexed solution for infusion to NHS Scotland. The Authority has awarded this Lot as a single supplier framework.
Delivery: Scotland
Lot 5 Pemetrexed Powder for Solution for Infusion
£2,531,443
Supply of pemetrexed powder for solution for infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 1 Paclitaxel Albumin Powder for Suspension for Infusion
£588,326
Supply of paclitaxel albumin powder for suspension for infusion to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework to two (2) Framework Participants.
Delivery: Scotland
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.